HEALTH

Spring forecast: Increase in allergy symptoms

BY Michael Johnsen

As spring approaches, people with allergies can blame global warming for some of their suffering, according to the American College of Allergy, Asthma and Immunology. Weather conditions have a significant effect on the levels of pollen and mold in the air, which affects the severity of allergies.

That suggests mold allergens could be particularly prominent this spring given the extent of drought across the United States — dry and hot weather lifts molds from the soil to be carried by the air. In addition to tree pollen, springtime mold contributes to hay fever.

As many as 9% of children suffer from such hay fever symptoms as itchy eyes, according to the Centers for Disease Control and Prevention. Homeopathic manufacturer Similasan last year identified seasonal eye allergies as a significant opportunity. At launch Similasan’s Kids Allergy Eye Relief was the only eye drop in the mass market formulated for children older than two years. "We wanted to create a solution for kids that is made with 100% natural active ingredients [and] is safe," Dan Quail, VP sales Similasan, toldDSN.With this launch, Quail suggested Similasan may have a comprehensive solution set for moms hoping to relieve symptoms of children with a cold or allergies — a homeopathic cough syrup for their throat, an ear drop solution for when a sinus infection extends into the ear cavity and now, a natural solution for itchy eyes.

During the upcoming three months, a much drier pattern is expected across the southern third of the nation, from central California to the eastern Gulf Coast.

 

 

The article above is part of the DSN Category Review Series. For the complete Homeopathy Buy-In Report, including extensive charts, data and more analysis, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Parents seek homeopathy for household

BY Michael Johnsen

A sick child leads to one certainty: parents in search of safe and effective symptom relievers that will allow their child — and subsequently, themselves — to get some rest.

That movement toward homeopathic remedies is reflected in the sales data. For example, SymphonyIRI Group vendor-level data for the 52 weeks ended Dec. 30, 2012, in the cough syrup sub-category, both Similasan and Hyland’s outpaced category growth of 4.6% with growth rates of 53.1% and 58.5%, respectively. And across cold and allergy liquid formulations, growth of No. 10 brand Hyland’s was tracking at 46.7% versus 11.5% for that entire category.

This cough-cold season Hyland’s launched its Defend-Plus line, an homeopathic cough-cold symptom reliever for adults. Hyland’s already has a share of the pediatric cough-cold market. Defend-Plus will help Hyland’s reach the mom buying cold medicines for the rest of the family.

 

 

The article above is part of the DSN Category Review Series. For the complete Homeopathy Buy-In Report, including extensive charts, data and more analysis, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Natural products to bloom in sales

BY Michael Johnsen

Homeopathy is hopping. Sales of many of the homeopathy brands represent some of the fastest-growing products across the OTC landscape these days, as evidenced by the number of brands escalating on the top 10 lists across several categories. Overall, sales of homeopathic medicines totaled $1.3 billion for the 52 weeks ended Dec. 22, up 8% according to SPINS, which tracks sales across both the natural channel (excluding Whole Foods) and mass retailers.

According to a survey conducted by the market research firm Kline, more than 45% of consumers consider natural OTCs like homeopathic products effective. And more than 40% believe that natural OTCs are safer and/or have fewer side effects than traditional OTCs.

Business opportunities vary across product categories, noted Laura Mahecha, industry manager at Kline’s Healthcare practice. "For instance, while cough and cold preparations are expected to grow at a rate of only 5% to reach $320.9 billion in 2016, it is anticipated that sleeping aids will grow by about 18% per year to reach $54 million in 2016 from $23.5 million reported in 2011," she said. "Growth in natural OTCs will be dependent on whether consumers continue to find them effective and safe."

Beyond opportunities within sleep, external analgesics containing arnica may become another growth driver. "You’re going to see the leg cramps and the arnica really come full force in the next 12 months," said Les Hamilton, VP sales for Hyland’s. Menthol rubs are common across the category, he added, and the homeopathic external analgesic solutions could supply some "newness" to the category.

 

 

The article above is part of the DSN Category Review Series. For the complete Homeopathy Buy-In Report, including extensive charts, data and more analysis, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES